BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15754732)

  • 21. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.
    Shimazu S; Nagamura Y; Yaguchi H; Ohkura N; Tsukada T
    Cancer Sci; 2011 Nov; 102(11):2097-102. PubMed ID: 21819486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.
    Sato K; Obara T; Yamazaki K; Kanbe M; Nakajima K; Yamada A; Yanagisawa T; Kato Y; Nishikawa T; Takano K
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5564-71. PubMed ID: 11701736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
    Howell VM; Cardinal JW; Richardson AL; Gimm O; Robinson BG; Marsh DJ
    J Mol Diagn; 2006 Nov; 8(5):559-66. PubMed ID: 17065424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature.
    Christakis I; Busaidy NL; Cote GJ; Williams MD; Hyde SM; Silva Figueroa AM; Kwatampora LJ; Clarke CN; Qiu W; Lee JE; Perrier ND
    Int J Surg; 2016 Jul; 31():10-6. PubMed ID: 27212590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.
    Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2621-6. PubMed ID: 9709921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1).
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Emmert-Buck MR; Debelenko LV; Lubensky IA; Zhuang Z; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Liotta LA; Collins FS; Chandrasekharappa SC; Spiegel AM; Burns AL
    J Intern Med; 1998 Jun; 243(6):447-53. PubMed ID: 9681842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
    Honda M; Tsukada T; Horiuchi T; Tanaka R; Yamaguchi K; Obara T; Miyakawa H; Yamaji T; Ishibashi M
    Intern Med; 2004 Apr; 43(4):310-4. PubMed ID: 15168774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism.
    Starker LF; Delgado-Verdugo A; Udelsman R; Björklund P; Carling T
    Endocrine; 2010 Dec; 38(3):397-401. PubMed ID: 20972721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
    Evans CO; Brown MR; Parks JS; Oyesiku NM
    J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
    Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
    Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
    Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
    Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia.
    Tahara H; Imanishi Y; Yamada T; Tsujimoto Y; Tabata T; Inoue T; Inaba M; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4113-7. PubMed ID: 11095441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.
    Cromer MK; Starker LF; Choi M; Udelsman R; Nelson-Williams C; Lifton RP; Carling T
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1774-81. PubMed ID: 22740705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
    Newey PJ; Nesbit MA; Rimmer AJ; Attar M; Head RT; Christie PT; Gorvin CM; Stechman M; Gregory L; Mihai R; Sadler G; McVean G; Buck D; Thakker RV
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1995-2005. PubMed ID: 22855342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
    Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
    J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop).
    Valdés N; Pérez de Nanclares G; Alvarez V; Castaño L; Díaz-Cadórniga F; Aller J; Coto E
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):309-13. PubMed ID: 10435055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative genetic pathways in parathyroid tumorigenesis.
    Farnebo F; Kytölä S; Teh BT; Dwight T; Wong FK; Höög A; Elvius M; Wassif WS; Thompson NW; Farnebo LO; Sandelin K; Larsson C
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3775-80. PubMed ID: 10523029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.